HSIF00 · House Standing

Energy and Commerce Committee

Committee on Energy and Commerce

Showing the 116th Congress (2019–2020). Back to the 119th Congress

2,228 bills referred in the 116th Congress

21,920 across the 13 Congresses on file, most in the 119th at 2,609. A referral is not a hearing: most bills sent to a committee are never taken up.

Bills referred, by Congress 107th to 119th

Members
55

Served in the 116th Congress

Subcommittees
6

Each with its own members and record

Meetings
10

Hearings and business meetings in the 116th Congress

Members, 116th Congress 55

Everyone who held a seat in the 116th Congress, leaders first, with the day they joined or left when it was not with the rest.

Subcommittees, 116th Congress 6

Under the names they had then. Each has its own record.

Record

Bills, meetings, hearings, reports and more, newest first. In the 116th Congress.

Reports, rules and messages sent to Congress by agencies and the President, and petitions and memorials, referred to this committee. Newest first. In the 116th Congress.

NumberCommunicationReferred
EC-4351A letter from the Director, Office of Congressional Affairs, Nuclear Regulatory Commission, transmitting the Commission's final rule - American Society of Mechanical Engineers 2015-2017 Code Editions Incorporation by Reference [NRC-2016-0082] (RIN: 3150-AJ74) received May 19, 2020, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104–121, section 251; (110 Stat. 868); to the Committee on Energy and Commerce.Executive communication · Nuclear Regulatory CommissionMay 22, 2020
EC-4350A letter from the Director, Office of Congressional Affairs, Nuclear Regulatory Commission, transmitting the Commission's regulatory guide - Regulatory Guide 1.151, Revision 2, "Instrument Sensing Lines" received May 1, 2020, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104–121, section 251; (110 Stat. 868); to the Committee on Energy and Commerce.Executive communication · Nuclear Regulatory CommissionMay 19, 2020
EC-4349A letter from the Director, Office of Congressional Affairs, Nuclear Regulatory Commission, transmitting the Commission's direct final rule - Individual Monitoring Devices [NRC-2019-0031] (RIN 3150-AK29) received May 1, 2020, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104–121, section 251; (110 Stat. 868); to the Committee on Energy and Commerce.Executive communication · Nuclear Regulatory CommissionMay 19, 2020
EC-4348A letter from the Director, Office of Congressional Affairs, Nuclear Regulatory Commission, transmitting the Commission's regulatory guidance - Regulatory Guide 8.39, Revision 1, "Release of Patients Administered Radioactive Material" received May 1, 2020, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104–121, section 251; (110 Stat. 868); to the Committee on Energy and Commerce.Executive communication · Nuclear Regulatory CommissionMay 19, 2020
PT-95The SPEAKER presented a petition of the City of Saint Paul, Minnesota, relative to Resolution No. RES 20-311, urging the United States Congress to enact without delay the Energy Innovation and Carbon Dividend Act of 2019, H.R. 763; jointly to the Committees on Ways and Means, Energy and Commerce, and Foreign Affairs.PetitionMay 15, 2020
PT-94The SPEAKER presented a petition of the Attorneys General of MA, CA, CT, DE, HA, IL, IA, ME, MD, MN, NJ, NY, NC, OR, RI, VT, VA, WA, and DC, relative to commending the Committee on Energy and Commerce for reporting out the "Alan Reinstein Ban Asbestos Now Act of 2019", H.R. 1603 (the "Reinstein Bill') and to express strong support for scheduling the4 bill for floor consideration with due dispatch; jointly to the Committees on Energy and Commerce and Education and Labor.PetitionMay 15, 2020
PT-91The SPEAKER presented a petition of Mr. Gregory D. Watson, a citizen of Austin, TX, relative to respectfully requesting passage of legislation which would incentivize American-based pharmaceutical manufacturers to produce prescription drugs domestically within the United States so as to eliminate - or at least reduce - America's dependency upon the fabrication of such medications in foreign nations and the concomitant danger of drug supply critical shortages; to the Committee on Energy and Commerce.PetitionMay 15, 2020
EC-4335A letter from the Director, Regulations Policy and Management Staff, Department of Health and Human Services, transmitting the Department's final rule - Medical Devices; Technical Amendments [Docket No.: FDA-2020-N-0011] received April 23, 2020, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104–121, section 251; (110 Stat. 868); to the Committee on Energy and Commerce.Executive communication · Department of Health and Human ServicesMay 14, 2020

By Congress

The committee's record in each Congress on file. Choose one to see the page as it stood then: its members, subcommittees and record. A dash means the official source has nothing that early, not that the committee did nothing.

CongressMembersBills referredReportedBecame lawReportsMeetingsPrinted hearingsCommunicationsPrints
119th2025–2026, sitting542,6091981711222499311
118th2023–2024532,5061831613024641,3400
117th2021–2022582,51594227914931,4660
116th2019–2020552,22815227111101281,4190
115th2017–2018561,7301284597141781,7140
114th2015–2016541,465883275101791,8791
113th2013–2014551,15860366111187—0
112th2011–2012571,1255017490186—0
111th2009–2010611,491792971—162—1
110th2007–2008611,530654660—154—3
109th2005–2006581,318553754—149—6
108th2003–2004591,114513750—133—0
107th2001–2002581,131562953—142—0

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress. Seats run from the 107th Congress, dated by the resolutions that made them and the Congressional Record; referrals and nominations from the 107th; meetings from the 112th. A committee older than that shows less than it has done. Records come from Congress.gov, GovInfo and the House and Senate.